Jitin Asnaani is on a mission to make nationwide health data exchange a reality. He is the first Executive Director of CommonWell Health Alliance, which is building a scalable infrastructure to enable health data to follow the patient regardless of where care occurs.
Prior to CommonWell, Jitin worked at athenahealth, where he focused on extending the company’s cloud-based interoperability platform and population health services. He also represented athenahealth in CommonWell Health Alliance, the Argonaut Project, DirectTrust.org and a number of Federal Advisory workgroups.
Previously, Jitin had been appointed to the Office of the National Coordinator for Health IT (ONC), where he helped incubate and launch the S&I Framework and led The Direct Project. Jitin continues to be an active member of the Federal Advisory Committees.
Jitin has a Bachelor’s degree in Computer Science & Engineering from MIT and a Masters in Business Administration from Harvard Business School.
Dr. Pat Basu, a Board Certified Physician, is the Chief Medical Officer of Doctor on Demand. He was previously the Chief Operating Officer, Chief Medical Officer, and Director on the Board at vRad – the largest technology enabled national radiology practice. Dr. Basu also served on the State Board of Health in Illinois. Dr. Basu helped shape economic and health care agendas during his time as a White House Fellow, and has also held faculty and research appointments at Stanford University that centered on health care cost, access and quality. Throughout his career he has consulted for Fortune 500 companies, venture capital firms, and major medical centers on growth strategy, cost containment, revenue enhancement, and operational optimization. Dr. Basu holds a Medical Doctorate and Masters in Business Administration from University of Chicago. He holds a degree in Mechanical Engineering from University of Illinois.
Paul Bleicher, MD, PhD, is the CEO of Optum Labs, an open, collaborative health care research and innovation center established by Mayo Clinic and Optum. Before this, he was CMO of Humedica, where he had responsibility for medical informatics, data analytics, and product management. Prior to Humedica, he was the founder of Phase Forward, the leading provider of integrated clinical trial data management software and safety solutions. Previously, he led clinical trials at a biotechnology company and a CRO. Dr. Bleicher trained in internal medicine and dermatology, and began his career as a physician/investigator on the faculty of MGH/Harvard Medical School.
Alexis Borisy is a Partner at Third Rock Ventures, where he focuses on the formation, development and strategy of new companies. He co-founded, served as interim CEO and is currently Chairman of the Board of both Foundation Medicine and Warp Drive Bio, and co-founded and served as interim CEO of Blueprint Medicines. He is also a Board Member of Editas Medicine and Revolution Medicine.
Brad Brooks is the Co-Founder and CEO of TigerText. He is also the Co-Founder of the secret-sharing app, Whisper. Before starting TigerText, Brad served as president for six years at DIC Entertainment, a children’s-branded media company that produced, distributed and licensed content globally. With the backing of Bain Capital, Brad acquired DIC from the Walt Disney Company in 2000, where he helped grow the company from less than $10mm of revenues to over $80mm. In 2005, he took the company public on the London Stock Exchange at a $200mm valuation. Prior to DIC, he worked for investment banking corporation Donaldson, Lufkin and Jenrette. Brad received his BA from UC Berkeley and an MBA from the University of Chicago.
Lynne Chou joined KPCB in 2013 and focuses on digital health and connected devices. She works alongside entrepreneurs to develop impactful technologies and therapies for improving patients’ lives.
Before joining KPCB, Lynne had over twelve years of healthcare operating and investing experience. She worked for eight years at Abbott Vascular and Guidant in multiple roles and worked on the launch of over ten interventional cardiology and cardiac surgery product families both in the US and internationally. Lynne also lead the global launch of Absorb, the world’s first bioresorbable vascular scaffold, recognized by WSJ as Medical Device Technology Innovation of the Year and Popular Mechanics. Lynne was responsible for building the global commercial strategy and therapy development as well as playing a key role in the clinical, reimbursement, operational strategy for the therapy.
Lynne earned her BS in industrial engineering from Stanford University and an MBA from Harvard Business School.
Todd invests in growth stage healthcare companies. Todd is currently a Director of AirStrip, Health Catalyst, MedExpress, Natera, PerfectServe, SVBio and ZirMed.
Prior to joining Sequoia Capital, Todd was the CEO of the Accountable Care Solutions business at Optum, the technology and services arm of UnitedHealth Group. Prior to that Todd was CEO of Picis, a provider of high acuity care electronic medical record software for hospitals acquired by UnitedHealth Group in 2010.
Earlier, Todd led Marquette Medical Systems to IPO and later sale to GE. Todd has a BA from Marquette University and is a graduate of the Harvard Business School PMD program.
Susan Dentzer is Senior Policy Adviser to the Robert Wood Johnson Foundation, and one of the nation’s most respected health care journalists and thought leaders.
An on-air analyst with PBS NewsHour and commentator on National Public Radio.
Dentzer served as editor-in-chief of Health Affairs, and led the NewsHour’s health unit. An elected member of the National Academy of Sciences and the Council on Foreign Relations; a fellow of the National Academy of Social Insurance and the Hastings Center. A Dartmouth graduate and trustee emerita; Dentzer holds an honorary master’s degree from Dartmouth and an honorary doctorate from Muskingum University.
She holds positions on boards including the Health Data Consortium, the International Rescue Committee, Research!America, American Board of Medical Specialties, the Public Health Institute, the Kaiser Commission on Medicaid and the Uninsured, the RAND Health Board of Advisors.
She, her husband, and their three children live in the Washington, DC area.
Sean Duffy is the co-founder and CEO of Omada Health, one of Fast Company’s “50 Most Innovative Companies in the World.” Omada Health is a digital health company dedicated to inspiring and empowering people everywhere to live free of chronic disease. The company’s flagship product, Prevent, is a 16-week, CDC-recognized program that lowers participants’ risk for obesity-related chronic disease using cutting-edge technology, world-class design, and the power of social networks.
An in-demand speaker and thought leader, Sean’s accolades include a spot on The San Francisco Business Times’ 2015 list of “40 Under 40,” J.P. Morgan’s list of the “100 Most Intriguing Entrepreneurs of 2014,” and Diabetes Forecast magazine’s list of “2014 Diabetes All Stars.”
Prior to Omada, Sean worked at both Google and IDEO. A former MD/MBA candidate at Harvard, he holds a BS in neuroscience from Columbia University.
Darren Dworkin is Senior Vice President of Enterprise Information Systems and Chief Information Officer of the Cedars-Sinai Health System in Los Angeles, California. Additionally, Mr. Dworkin is the co-founder of Stanson Health (www.stansonhealth.com) and the managing director of Summation Health Ventures (www.shv.io). Mr. Dworkin has spent over 25 years in information Technology and over 15 in healthcare.
At Cedars-Sinai he has led the implementation of a comprehensive electronic medical record to help transform care through the use of advanced technology. Day to day Mr. Dworkin leads the strategy and technology operations of both the information and clinical technology teams. The Cedars-Sinai technology team has been recognized for the past 6 years as one of Computerworld’s best places to work in IT, recognized as one of the 100 most wired hospitals in the country, and a holder of the prestigious HIMSS level 7 award.
At Stanson Health he has helped to create a software solution to deliver real-time Clinical decision support at the point of care. Stanson aims to reduce low-value and unnecessary care by leveraging real-time alerts and relevant analytics to guide and influence physician’s decisions.
At Summation Health Ventures, Mr. Dworkin leads select investments and portfolio companies aligned with Summation Health Venture’s goals of providing strategic funding to privately held companies offering innovative products, services and technologies which help health care systems significantly improve performance and outcomes.
Prior to joining Cedars-Sinai, Mr. Dworkin held the position of Chief Technology Officer at Boston University Medical Center in Boston, MA. Where he led the development and deployment of the infrastructure and application framework to bring technology to the point of care.
Mr. Dworkin has been a leader helping major information technology vendors bring solutions to the healthcare vertical enabling improvements in workflow, quality and value.
Mr. Dworkin is presently on the advisory boards of Dell, AT&T, Philips, Avia, Next Wave Health, and The Scottsdale Institute.
Mr. Dworkin is a member of HIMSS, CHIME, The Wall Street Journal CIO Network, and IEEE.
A native of Montreal, Canada, Mr. Dworkin lives in Los Angeles with his wife and two daughters.
Terry Edwards is the visionary founder, president and CEO of PerfectServe. As chief executive, Edwards has dedicated himself to helping clinicians provide the best and most efficient patient care-while delivering most satisfying customer experience in the healthcare industry.
Edwards invented and developed the version one prototype of what has today evolved into the most comprehensive and secure communications and collaboration platform in the healthcare industry.
The company currently serves nearly 100,000 clinical users—including more than 50,000 physicians—in some of the leading U.S. health systems, including Advocate Health Care, Ascension Health, MemorialCare, WellStar, Memorial Hermann, St. Joseph Health and more.
Prior to starting PerfectServe, Edwards served as vice president of sales for Voice-Tel, a pioneer in the interactive voice messaging industry. Previously, he co-founded Milepost Corporation, a leading mid-west marketing communications firm. Before launching into entrepreneurial ventures, Edwards studied music at Bowling Green University and religion at Lourdes College.
Helmy Eltoukhy oversees the strategic company vision and direction in his role as CEO and co-founder of Guardant Health. Helmy is a leading expert in the biotech industry and brings years of experience pioneering new technologies to Guardant Health.
Prior to co-founding Guardant Health, Helmy was the senior director of scientific research at Illumina. In this role, he was responsible for the development of novel chemistries, hardware, and informatics for genetics analysis systems. Prior to Illumina, Helmy successfully co-founded and guided Avantome from an early stage startup to a successful leader in low-cost sequencing technologies acquired by Illumina in 2008.
Helmy began his career at the Stanford Genome Technology Center. It was here where he invented the first semiconductor sequencing platform and the first base-calling algorithm for next-gen sequencing, sparking a true passion for democratizing healthcare through application of advanced technologies. He earned his PhD, MS and BS degrees in electrical engineering from Stanford University.
Dr. Ferris is a practicing primary care physician and SVP for Population Health Management at Partners HealthCare in Boston and an Associate Professor at Harvard Medical School. He holds degrees from Middlebury College, Oxford University, Harvard Medical School, and the Harvard School of Public Health. He leads the Partners Healthcare Pioneer Accountable Care Organization, responsible for design and implementation of system-wide care delivery changes that will improve patient health, improve patient experience of healthcare, and reduce the healthcare cost burden. He has over 90 publications in healthcare quality measurement, risk adjustment, population management, and information technology. Dr. Ferris has served on multiple committees for the Institute of Medicine, Agency for Healthcare Research and Quality, and National Quality Forum where he chaired the Consensus Standards Approval Committee. He has served as a consultant to the Congressional Research Service, National Governor’s Association, the World Health Organization, and the Institute for Healthcare Improvement.
Bill is a Partner at Flare Capital Partners, a team of proven healthcare technology venture capital investors known for delivering unrivaled strategic industry resources, insight and a total commitment to the success of the entrepreneurs with whom we have the privilege of partnering. Current and prior investments include Valence Health, ClearDATA, Iora Health, Predilytics (Welltok), Humedica (Optum Analytics), Explorys (IBM), Connance, Rise Health (Best Doctors), Pharmetrics (IMS Health) and eBenX (ADP). Prior to cofounding Flare Capital Partners in 2013, Bill was with North Bridge Venture Partners since its inception in 1994.
Michael Hanewich, Head of Life Science and Healthcare Venture Capital relationships in the US and Europe, is one of the industry’s leading venture capital experts. Boston-based Hanewich brings more than 25 years of commercial banking experience and extensive expertise within Healthcare/Life Science companies, venture capital firms, corporate venture capital, entrepreneurs, accounting and law firms.
Hanewich is nationally known for his Venture Capital Training Series and is on the advisory board of the Digital Healthcare Innovation Summit. He is a frequent speaker appearing at top venture capital CEO summits and prestigious academic institutions worldwide. Hanewich is an expert moderator and panel member of top-tier global industry events including the Biotech in Europe Investor Forum, BIO CEO & Investor Conference, Boston Biotech Conferences (BBC). He was honored with Silicon Valley Bank’s Biggerstaff Award in 2010 for individuals who exemplify the Company’s Guiding Principles and demonstrate outstanding leadership, client focus and extra-ordinary performance.
Before joining Silicon Valley Bank in 1999, Hanewich was Executive Vice President at Flagship Bank and Trust Company for ten years and was instrumental in developing their biotechnology business and financing and treasury management services. Prior to joining Flagship Bank and Trust, Hanewich was with the Dun & Bradstreet Corporation.
Hanewich holds a bachelor’s degree from Eckerd College in St. Petersburg, Florida where he is a member of Tritons Hall of Fame for baseball. He holds a graduate degree from The Stonier Graduate School of Banking at the University of Delaware.
Brad Hively is the President of Health Essentials Physician Network and GeriNet Medical Associates.
Founded in 1996, Health Essentials is a care delivery organization for high risk patients with advanced illness. Through our Medical Group (GeriNet), our IPA (Health Essentials Physician Network), and our 8 Hospices we provide compassionate, accountable care to post-acute, palliative, and hospice patients.
Prior to joining Health Essentials, Brad was Senior Vice President, Medical Group Operations, for Heritage Provider Network, a Knox-Keene licensed medical group and IPA that manages care for over 700,000 lives on an at-risk basis.
Earlier in his career Brad was a healthcare investor with TA Associates and General Atlantic.
Regarded as a subject matter expert in healthcare management, Brad currently serves as an Adjunct Professor for USC’s Masters of Health Administration program. Brad received a BA in Business Economics, from UCLA and an MBA from Stanford University’s Graduate School of Business.
Brandon Hull is Co-Founder and Managing Partner of Cardinal Partners, a medical and life sciences venture capital partnership established in 1996. He began his career as a VC in 1991 as a principal of the Edison Venture Fund, where he directed healthcare investing activities and served on the boards of the fund’s healthcare portfolio companies. His extensive investment experience includes all facets of health care services, information systems, medical products & devices, as well as a variety of IT companies in other vertical sectors. Brandon has been a pioneer investor in cloud-based, SAAS HIT companies, and was a first-round investor in such notable companies as Athenahealth, Coderyte, Visicu, and Intellicare.
Brandon currently serves as a director of AthenaHealth (Lead Director), Awarepoint, Brighton Health/Privia, CureAtr, QPID, Vitals, Ivenix and Teladoc (observer).
Brandon received his BA from Wheaton College (IL) and his MBA from The Wharton School of the University of Pennsylvania.
Kevin King joined iRhythm in July 2012 as President, CEO, and Director, after nearly three decades of experience in the healthcare and IT industries in leadership roles. Most recently he was the President and CEO of Affymetrix, a publicly traded technology innovator in the field of genetic analysis, where he defined and led a growth strategy into new markets for downstream validation and molecular diagnostics and oversaw several acquisitions. Kevin’s business expertise spans a diverse range of markets and technologies including: genetic analysis, medical devices, enterprise clinical information systems and healthcare services for business and clinical decision support.
Prior to Affymetrix, Kevin was President and CEO of Thomson Healthcare, a $500M information services business focused on a range of healthcare-related businesses. Through product innovation, acquisition and divestiture, he strategically repositioned the business within the growing markets for data-driven services. Previously, Kevin was a senior executive at GE Healthcare, where he led several business units including Magnetic Resonance Imaging and the $900M Global Clinical Systems Business. Kevin began his career at HP’s Medical Products Group and during his fourteen year tenure held leadership roles in Sales, Marketing, R&D, and Business Development.
Kevin earned his B.A. from the University of Massachusetts in Economics and Biology and holds an M.B.A. from New Hampshire College.
William King is the founder and Chief Executive Officer of Zephyr Health; the Insights-as-a-Service leader harnessing the power of global health data to address critical business and patient needs. He drives the company’s vision, strategy and growth with a passion for real-world business solutions and actionable enterprise data and insight solutions. Under William’s leadership, Zephyr Health has grown to serve leading pharmaceutical, biotech and medical device companies across more than 15 countries. The company has operations in North America, United Kingdom and India and stands at the forefront of the digital health economy.
Previously William has held a range of global roles in sales, marketing, training and strategy with multi-national Johnson & Johnson. William holds a Bachelor of Science in Business Administration from the University of Denver and currently serves on the American Heart Association Research Roundtable Executive Board.
Stephen Kraus is a Partner at Bessemer Venture Partners, leading up the firm’s healthcare investment practice.
Steve has been recognized by Forbes Magazine as one of the top healthcare investors in the industry. Prior to joining Bessemer, Steve worked for a growth-stage, private-equity firm and as management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.
Steve graduated summa cum laude with a B.A. from Yale University and earned his MBA from Harvard, where he was a Baker Scholar. Steve currently serves as chair of the New England Venture Capital Association (NEVCA) and the Achievement Network.
Shawn Leavitt is the SVP of Global Benefits for Comcast Cable, NBCUniversal & Comcast Spectacor —one of the world’s largest media & technology companies. In this role, Shawn and his team are responsible for delivering Retirement, Health & Welfare, and Health Services programs in support of the company’s 139,000 employees. Over his 20+-year career—which has included strategic positions at Carlson, Safeway Inc., The Coca-Cola Company, and Knight-Ridder—Shawn has developed a reputation for innovation. He has implemented creative, integrated compensation and benefit strategies; managed rewards in complex global settings; developed effective employee total rewards and wellness campaigns and pioneered the “Health Advocate” model that is now a core function of any effective care management strategy.
Harry Leider, MD, MBA has over 25 years experience as a senior physician executive in a variety of innovative healthcare organizations. Currently, he is Chief Medical Officer and Group Vice President of Walgreens – responsible for developing enterprise-wide health and wellness services that provide customer value and improve patient lives. Prior to joining Walgreens, Dr. Leider was Chief Medical Officer and Senior Vice President of Ameritox, a national specialty laboratory providing medication monitoring services to physicians treating chronic pain and serious mental illness. Previously, he served as Chief Medical Officer of XLHealth, a national Disease Management company and Medicare health plan that supported seniors with common chronic illnesses.
Earlier in his career, Dr. Leider was Senior Vice President of Interactive Forums, Inc. a national healthcare market research and strategy company; and founder and President of IFI Health Solutions – its consulting division that provided services to a broad range of healthcare technology, managed care, provider, and pharmaceutical organizations – in the areas of: qualitative market research, population health, leadership training for physician executives, and clinical quality improvement.
In addition to his extensive background in population health, healthcare consulting, and market research, Dr. Leider has broad experience in managed care. He served as the Chief Medical Officer and Senior Vice President of Health Services for HealthNet, a large hospital-owned managed care organization in Kansas and Missouri, and developed all of the care management programs for multiple new health plans. Previously, Dr. Leider managed the Boston Health Center of Harvard Community Health Plan (one of the country’s leading managed care organizations.) In this role, he was the senior executive responsible for the operation of a large, urban, multi-specialty health center that employed over 40 physicians, 200 staff, and served over 25,000 members.
Dr. Leider has received national recognition for his innovative approach to developing care management programs for populations with chronic illness, educating physicians on how to be more effective leaders, and teaching executives how to improve the quality of healthcare. He speaks frequently to national audiences and serves as a fellow, core faculty member, past board member and President of the American Association of Physician Leaderhsip (AAPL). In recognition of his major contributions to leadership in healthcare, in April of 2015, Dr. Leider was awarded the designation of Distinguished Fellow by AAPL. In addition to his faculty role at AAPL, Dr. Leider recently served as a Professional Faculty member at the Johns Hopkins Carey School of Business.
Dr. Leider served on multiple Boards of healthcare organizations. In addition to his role at AAPL, he was a founding board member of the Disease Management Association of America (DMAA), served on the Board of the Institute of Aging at the University of Pennsylvania, is currently a Board Advisor to Tytocare, and recently joined the Board of the eHealth Initiative.
Dr. Leider’s publications appeared in a variety of peer-reviewed journals and books including the American Journal of Managed Care, the journal Population Health Management, The Physician’s Guide to Managed Care by Aspen Publishers, and two books published by AAPL: the Essentials of Medical Management and Practicing Medicine in the 21st Century. He also serves on the editorial boards of the Physician Executive Journal, and Population Health Management.
Dr. Leider obtained a BA from Pennsylvania State University, earned his MD from the University of Pennsylvania School of Medicine, and while a Robert Wood Johnson Clinical Scholar, earned his MBA from the University of Washington Foster School of Business. He served for six years as an attending physician at Brigham and Women’s Hospital in Boston and as a faculty member at Harvard Medical School.
Dr. Leider lives in Evanston, IL with his wife Reena and their two daughters.
Dr. David McCallie, senior vice president, Medical Informatics, and Cerner Engineering Fellow is responsible for leading the research and development team focused on innovations at the intersection of computer science and clinical medicine. His current research targets applications of semantic content extracted from the clinical record using natural language parsing techniques.
Dr. McCallie joined Cerner in 1991 as the chief architect for Open Clinical Foundation, Cerner’s clinical data repository, which sits at the center of Cerner Millennium®. He was also responsible for the development of Cerner’s UMLS-derived clinical nomenclature system and for the PowerNote™ structured clinical documentation tool, now in widespread use at Cerner client sites.
Dr. McCallie earned a bachelor’s degree in electrical engineering from Duke University, and a medical degree from Harvard Medical School. He published numerous works and presented frequently on the subject of healthcare informatics. He is an active member of the American Medical Informatics Association.
Stephen McHale is co-founder and Chief Chairman and Executive Officer of Explorys. Formed in partnership with Cleveland Clinic, Explorys addresses the national imperative to leverage electronic health records (EHR) for the improvement of medicine. Our network accelerates discovery of critical correlations, trends, and outcomes across millions of patients, clinical records, and diverse topologies providing unique insight to enable providers and life sciences organization to deliver safer, more efficient, and more effective healthcare.
Stephen has had a 25-year career in founding, investing in and building technology companies.
He is recognized for his focus in data mining and business intelligence related ventures. Most
recently he served as the Chairman and Chief Executive Officer of Everstream, the company he
founded in 1999. Everstream is the largest census level media measurement, data warehousing,
and analytics platform in the world, measuring usage across 25 million households. Sold to Concurrent [NASDAQ: CCUR] in 2005, it continues to be the industry leader of enterprise software for broadband network usage measurement.
In 1985, Stephen founded McHale and Associates, Incorporated, a USConnect regional office where he served as Chairman and Chief Executive Officer. Stephen was a founding investor and served on the board of directors and as CEO of USConnect, an international systems integrator. USConnect generated aggregate revenues of $150 million until its sale to IKON Office Systems [NYSE: IKN] in 1997. Stephen is also Managing Director of 23Bell LLC Investments and an active Advisory Board Member to Genesis Inventions.
Stephen serves on the board of directors for the Center for Families and Children; a non-profit organization that makes success possible for people in Northeast Ohio’s most challenged communities. Stephen serves on the investment screening committee for the North Coast Angel Fund. He is also an active member of the Entrepreneurs Organization and Kent State University’s Health Informatics Advisory Council.
Robert Mittendorff brings to Norwest Venture Partners more than a decade of operational and medical experience. Based in Norwest’s Palo Alto office, Robert focuses on investing capital in venture and growth opportunities in the healthcare sector, including digital health and healthcare IT, technology enabled healthcare services, medical devices, diagnostics, and specialty pharma. He currently serves on the board of iCardiac, and is a board observer at Crossover Health, iRhythm, and Telcare, and was involved with the initial investments in Misfit Wearables and Health Catalyst. He has also been involved in Norwest’s follow-on investment in Basis (acquired by Intel). Robert was a previous board observer at Intersect ENT (Nasdaq: XENT).
Prior to Norwest, Robert was the Vice President of Marketing and Business Development at Hansen Medical Inc. (Nasdaq: HNSN). During his tenure, he launched multiple products, including the Magellan and Sensei X robotic systems, and was involved in leading products from concept to first commercial shipment. As a corporate officer, Robert also led the Company’s partnerships with GE, Siemens, Philips and St. Jude Medical and executed transactions totaling over $100M. He created the Scientific Advisory Board and participated in two public financings.
Prior to Hansen Medical, Robert worked in the device, pharmaceutical and biotech industries with experience at a number of companies, working in strategic, business development and marketing capacities.
Robert is also a board certified emergency physician who completed his residency training at Stanford. Robert received his M.D. from Harvard Medical School and his M.B.A. from Harvard Business School. He received his B.S. in biomedical engineering from Johns Hopkins University where he played on the soccer team. He has completed fellowships under the Howard Hughes Medical Institute (neuroscience), MIT Sloan School of Management, and Harvard Business School.
Rick is the founder and CEO of Comprehend, where he is responsible for the overall direction, vision and day-to-day operations. Comprehend is a cloud-based, software solution that enables pharmaceuticals, biotechs, and medical device makers to continuously improve quality and speed of their clinical trials. Prior to Comprehend Systems, Rick spent nearly a decade developing commercial software tools used by the FDA and top pharmaceutical companies. Rick holds a bachelor’s degree in Computer Science from Carnegie Mellon University in Pittsburgh, Pennsylvania.
Ulrich Muehlner is currently Global Head Outcomes Technologies Incubator (NOVAE) at Novartis. In this global and Group-wide role, he is leading/supporting programs aiming at increasing the value of the Novartis portfolio through sourcing, licensing, shaping and commercially integrating “beyond-the-drug” (digital) technologies that enable or enhance the real-world outcomes performance of Novartis products. Examples of such partnerships include the “smart lens” deal with Google(x) and the investment into the “smart pill” company Proteus Digital Health.
Ulrich joined Novartis in August 2009 as Director Corporate Strategy, leading key Group initiatives in areas such as emerging markets, digital health, innovation-driven growth opportunities and venturing. From August 2012 – April 2013, Ulrich was Global Head Corporate Strategy (a.i.) and developed the portfolio strategy that resulted in the fundamental transformation of the Novartis business portfolio.
Prior to Novartis, Ulrich worked with BCG, studied Biochemistry and earned a PhD in Biochemistry and Molecular Biology.
Tom Peterson is the Chief Operating Officer and co-Founder of Evolent Health. Evolent Health partners with leading health systems to drive value-based care transformation. At Evolent, Tom oversees all aspects of operations across our health system partners in over 25 markets covering over 600,000 individuals in various value-based care arrangements. In this capacity, Tom is accountable for all of Evolent’s clinical implementation and operations functions, health plan strategy and operations, pharmacy services and market-based operations. Prior to Evolent, Tom was the Executive Director of The Advisory Board Company, overseeing the Business Intelligence and Consulting businesses. He has also held leadership roles in managed care and capitation management services with HealthSouth Corporation and Foundation Health. Tom has a Masters in Mental Health Counseling from The George Washington University and a Bachelors of Arts from Harvard University.
Anita Pramoda is the CEO of Owned Outcomes, a health analytics company that has helped >100 hospitals succeed in various value based care initiatives and bundled payments. Anita was recently the CFO at Epic Systems, a $2 billion healthcare IT company, that provides electronic medical records for >40% of the US population. Anita led Epic through a period of significant domestic market growth, its expansion into the governmental and international markets, and its launch into mobile health IT solutions. Prior to Epic, Anita helped commercialize self-healing packaging technology at Ontech. Earlier in her career, Anita worked with companies in the technology and healthcare sectors on strategic advisory and financing assignments at UBS Investment Bank and Arthur Andersen. She serves on the board of directors at Dignity Health Foundation and Allscripts (Nasdaq: MDRX).
Anita is an engineer and holds a MBA from The Wharton School, University of Pennsylvania.
Ojas Rege is VP Strategy at MobileIron. His perspective on enterprise mobility has been covered by Bloomberg, CIO Magazine, Financial Times, and Forbes. He coined the term “Mobile First” on TechCrunch in 2007, one week after the launch of the first iPhone, to represent a new model of personal and business computing. He is co-inventor on five mobility patents, including the enterprise app store and BYOD privacy policies. Ojas has been with MobileIron for seven years as the company has grown from just an idea into the fastest growing technology company in the world (Deloitte Technology Fast 500 December 2014). Prior to MobileIron, Ojas was responsible for the mobile product teams at Yahoo! and AvantGo and started his career in 1988 as product line manager at Oracle. Ojas has a BS/MS in Computer Engineering from M.I.T. and an MBA from Stanford University.
A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.
Prior to working at Elsevier, he served as senior staff writer at Windhover Information and news editor at Dow Jones where he edited the Venture Capital Analyst: Health Care, a monthly newsletter. He also oversaw the daily life science coverage of VentureWire. Before leading those publications, Tom covered Boston’s health care and life science industries for the Boston Business Journal and worked at several newspapers in the Boston area.
A lifelong resident of the Commonwealth of Massachusetts, Tom graduated from Boston University and still resides in the Boston area with his wife and two sons.
Paul is responsible for global product marketing at Veeva Systems where he has held senior leadership roles since 2011. Before Veeva, Paul ran the Life Sciences business unit at SAP with responsibility for product strategy and solutions globally. Prior to SAP, Paul held product marketing leadership roles at Proscape and Siebel. Paul is widely recognized as an early pioneer and evangelist in transforming life sciences selling technology with closed loop marketing (CLM) and is credited with selling and implementing some of the industry’s earliest deployments. Paul received his MBA from the Harvard Business School and his B.S. in Chemical Engineering from Bucknell University.
Dr. Shreeve is an Emergency Medicine physician who has been actively involved in the design, development, and distribution of health technologies that improve the delivery of care and enhance the quality of life. He is the founder and chief executive office of Crossover Health, a next generation health care delivery and management services company. Dr. Shreeve was a co-founder of Medsphere Systems Corporation, the first open source electronic health record for the healthcare enterprise. Dr. Shreeve is also founding member of the Health 2.0 technology and reform movement, serving as an advisor to the conference and spokesperson throughout the country. He earned his undergraduate degree from Brigham Young University, graduated from University of Utah School of Medicine, and completed his Emergency Medicine residency at the University of Arizona. He lives in Southern California with his wife and four children near some of the best surf breaks on the west coast.
Lesley Solomon’s passion for innovation was fostered out of her many experiences at startups creating new revenue models, building brands and growing high-impact teams. As the Executive Director of the Brigham and Women’s Hospital Innovation Hub she is responsible for leading a team working with clinicians and scientists to help them realize their dreams of transforming ideas into innovations to impact patient care.
Lesley is also the Director of Strategy and Innovation in the Brigham Research Institute, leading the hospital’s effort in deepening its relationship with the biotechnology and pharmaceutical industries to accelerate science from bench to bedside.
She brings forth 20+ years of experience as an executive working in business development, strategy, and marketing at startups, early stage, and large companies such as the Food Network, Barnes & Noble.com, and Yoga Works. Lesley received her MBA from Harvard Business School and has a B.A. in English from Cornell University.
Tom Spann is Chief Executive Officer and co-founder of Accolade, Inc., an innovative consumer services company dedicated to improving the healthcare experience and helping individuals and families get the right care the first time.
Since its founding in 2007, Accolade has grown to 600-plus employees serving some of the nation’s largest self-insured employers together with health plans and health systems. Accolade has been recognized as one of the nation’s 25 Most Promising Companies by Forbes magazine and the fastest-growing private healthcare company by Inc. 500. Employees have consistently voted the company a top workplace in the Philadelphia region and Tom a top CEO.
Prior to founding Accolade, Tom served as Senior Managing Partner at Accenture, where he led the North America Products Group, a 10,000-employee operating unit with $2-billion-plus-revenue.
Tom holds a bachelor’s degree in economics from the Wharton School of the University of Pennsylvania.
Russell Staheli is a leader in healthcare analytics, creating actionable stories from healthcare data since 2001. He has a Masters in Health Policy and Administration from UNC Chapel Hill and an Undergrad in Health Services Research.
Russ started at Intermountain Healthcare supporting the Primary Care Clinical Program along with the Advanced Training Program (ATP) for Executives & QI Leaders. Before joining Health Catalyst in 2011, he lead the analytical efforts within Infection Control and Epidemiology at the Duke University Health System. While there, he also consulted the advancement of analytics in the Duke Infection Control Outreach Network (DICON).
At Health Catalyst, Russ’s primary accountability on the product development leadership team is creating analytics that drive cost, quality and satisfaction improvements across health systems.
Russ lives in Salt Lake City, Utah with his wife and five very active kids.
Earl Steinberg, MD is a nationally known expert in evaluation and improvement of the quality and efficiency of health care. Dr. Steinberg was the Executive Vice President of Innovation & Dissemination, and Chief, Healthcare Solutions Enterprise at the Geisinger Health System from June 2011 through September 2015. Prior to joining Geisinger, Dr. Steinberg was Senior Vice President for Clinical Strategy, Quality and Outcomes at WellPoint, Inc., and President and CEO of Resolution Health Inc. (RHI), a leading health care data analysis company that provides innovative quality improvement and cost reduction services to health plans, employers, PBMs and disease management companies. Dr. Steinberg also is an Adjunct Professor of Medicine and of Health Policy and Management at Johns Hopkins University. Prior to joining RHI, Dr. Steinberg spent six years as Vice President of Covance Health Economics and Outcomes Services Inc., Director of its Quality Assessment and Improvement Systems (QAIS) Division, and Co-Director of its Outcomes Studies Group (OSG). Dr. Steinberg also spent 12 years on the full-time faculty at Johns Hopkins University where he was Professor of Medicine and of Health Policy and Management as well as Director of The Johns Hopkins Program for Medical Technology and Practice Assessment. Dr. Steinberg also served four years on the Federal Physician Paymentf Review Commission (PPRC).
Dr. Steinberg received his A.B. degree from Harvard College (Summa Cum Laude), his M.D. from Harvard Medical School and a Master of Public Policy degree from the Kennedy School of Government. His residency training in internal medicine was performed at the Massachusetts General Hospital.
Dr. Steinberg has received numerous awards, including the Henry J. Kaiser Family Foundation Faculty Scholar Award in General Internal Medicine (1984), the “Outstanding Young Investigator” Award from the Association for Health Services Research (1988), and a Special Presidential Visionary Award from the National Kidney Foundation (2004) for his work as the scientific director of the NKF’s landmark Kidney Disease Outcomes and Quality Initiative, which produced over 250 clinical practice guidelines for management of patients with end stage renal disease. He is also a Fellow of both the American College of Physicians and Academy Health and has published more than 125 articles in peer reviewed journals.
Dr. Krishna Yeshwant is a physician, programmer, and entrepreneur who has been working with Google Ventures since its inception. He first joined Google as part of the New Business Development team.
Prior to Google he helped start an electronic data interchange company that was acquired by Hewlett-Packard and a network security company that was acquired by Symantec. He also co-authored the business plan for Diagnostics For All, which won both the Harvard Business School and MIT $100k business plan competitions.
Previously, Krishna published several book chapters and journal articles in the field of computer-guided surgery, completed research in tissue engineering, and developed and licensed multiple surgical devices. He has worked with the technology transfer offices of MIT, Harvard, and Massachusetts General Hospital.
Krishna has a B.S. in computer science from Stanford University. He also earned an M.D. from Harvard Medical School, an MBA from Harvard Business School, and completed his residency at Brigham and Women’s Hospital in Boston, MA where he continues to practice.
Steve has over 30 years of experience launching and managing health care companies and has founded seven health care companies including Oxford Health Plans, which grew into a Fortune 300 company under his leadership. Steve is a Managing Director of Essex Woodlands, one of the oldest and largest health care venture capital and growth equity firms. He was also the Founder, Chairman and CEO of HealthMarket, Inc., an insurance company that gave birth to innovative Consumer Driven Health Plans. He co-founded Health Partners, Inc, a physician practice management company. He was also a co-Founder of Intelliclaim, Inc., which provided claim auditing and productivity software and services to over twenty health insurance companies before it was sold to McKesson, and he was the founding investor in BenefitPort, LLC, a consolidation of health insurance general agencies.
Steve graduated from Macalester College and has an MBA from Harvard Business School.
The same technologies that revolutionized the commerce, transportation, and finance industries are bearing down on the $3 trillion healthcare industry, promising to simultaneously improve care while reducing costs. The scope of revolutionary technologies includes diagnostics and monitoring, wearable devices, telehealth, medical modeling, smart devices, data management, tracking and delivery, and much more.
But innovators won't find the solutions without completely understanding the problem.
The Digital Healthcare Innovation Summit emphasizes disruptive solutions to the Health Care conundrum. Leading stakeholders from hospitals, insurers, and critical regulatory bodies sit down with the technology industry’s top innovators, investors, and entrepreneurs to discuss how technology can unwrap the inefficiencies of the massive healthcare sector. This isn’t a showcase of gadgets. It’s the source of the conversation for healthcare solutions and opportunities, delivered through new and innovative technologies.
Join us at the 5th annual Digital Healthcare Innovation Summit to learn about emerging technologies that will impact the economics of care and improve the ways we prevent and treat illness.
776 Boylston Street, Boston, MA 02199